| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-05 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |